rss
BMJ Case Reports 2009; doi:10.1136/bcr.09.2008.0927
  • Novel treatment (new drug/intervention; established drug/procedure in new situation)

Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP

  1. Hans W Axelson1,
  2. Gunnar Öberg2,
  3. Håkan Askmark3
  1. 1
    Clinical Neurophysiology, Uppsala University Hospital, Uppsala, SE-751 85, Sweden
  2. 2
    Haematology, Uppsala University Hospital, Uppsala, SE-751 85, Sweden
  3. 3
    Neurology, Uppsala University Hospital, Uppsala, SE-751 85, Sweden
  1. hans.axelson{at}akademiska.se
  • Published 2 February 2009

Summary

Chronic inflammatory demyelinating polyneuropathy (CIDP) is characterised by the occurrence of symmetrical weakness and sensory impairment in arms and legs. The course is relapsing or chronic and progressing. CIDP is considered to be an autoimmune disease, which is supported by the beneficial response to immunomodulating therapies in most patients. We report on a patient with CIDP who has been in remission for more than 3 years after treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP on two occasions.

Footnotes

  • Competing interests: None.

This Article

  1. Summary
  2. Full text

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog